15 analysts have shared their evaluations of Couchbase BASE during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 5 | 6 | 4 | 0 | 0 |
Last 30D | 3 | 5 | 3 | 0 | 0 |
1M Ago | 0 | 1 | 1 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 2 | 0 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.0, a high estimate of $30.00, and a low estimate of $19.00. This current average represents a 12.31% decrease from the previous average price target of $26.23.
Deciphering Analyst Ratings: An In-Depth Analysis
A comprehensive examination of how financial experts perceive Couchbase is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Matthew Hedberg | RBC Capital | Maintains | Outperform | $25.00 | $25.00 |
Andrew Nowinski | Wells Fargo | Lowers | Overweight | $23.00 | $30.00 |
Ittai Kidron | Oppenheimer | Lowers | Outperform | $23.00 | $25.00 |
Raimo Lenschow | Barclays | Lowers | Equal-Weight | $19.00 | $20.00 |
Rudy Kessinger | DA Davidson | Lowers | Buy | $25.00 | $30.00 |
Brad Reback | Stifel | Lowers | Buy | $20.00 | $25.00 |
Austin Dietz | UBS | Lowers | Neutral | $19.00 | $24.00 |
Sanjit Singh | Morgan Stanley | Lowers | Equal-Weight | $27.00 | $29.00 |
Rob Oliver | Baird | Lowers | Outperform | $27.00 | $32.00 |
Mike Cikos | Needham | Maintains | Buy | $22.00 | $22.00 |
Brent Bracelin | Piper Sandler | Lowers | Overweight | $21.00 | $22.00 |
Raimo Lenschow | Barclays | Lowers | Equal-Weight | $20.00 | $27.00 |
Brent Bracelin | Piper Sandler | Announces | Overweight | $22.00 | - |
Mike Cikos | Needham | Announces | Buy | $22.00 | - |
Howard Ma | Guggenheim | Maintains | Buy | $30.00 | $30.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Couchbase. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Couchbase compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Couchbase's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of Couchbase's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Couchbase analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Unveiling the Story Behind Couchbase
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.
Couchbase's Economic Impact: An Analysis
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Couchbase showcased positive performance, achieving a revenue growth rate of 25.2% as of 30 April, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Couchbase's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -40.9%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Couchbase's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -16.18%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Couchbase's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -8.56%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Couchbase's debt-to-equity ratio is below the industry average. With a ratio of 0.03, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Basics of Analyst Ratings
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.